AONC (American Oncology Network) Risk Assessment

View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of American Oncology Network is: No Data: Cannot be evaluated.

Competitive Comparison of American Oncology Network's Risk Assessment

For the Medical Care Facilities subindustry, American Oncology Network's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Oncology Network's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's Risk Assessment distribution charts can be found below:

* The bar in red indicates where American Oncology Network's Risk Assessment falls into.

American Oncology Network (OTCPK:AONC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

American Oncology Network Risk Assessment Related Terms

Thank you for viewing the detailed overview of American Oncology Network's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oncology Network Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (OTCPK:AONC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913

Website

https://www.aoncology.com

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care needed to achieve optimal health outcomes.

Executives

Stephen Divers	director, officer: Chief Medical Officer	133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913
Todd Schonherz	director, officer: Chief Executive Officer	14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
David H Gould	officer: Chief Financial Officer	7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907
Erica Mallon	officer: General Counsel	14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913
Shalin Shah	director	3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607
Vipul M Patel	director	11704 SE 15TH CIRCLE, OCALA FL 34480
Vance Wright-browne	director	22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980
James Stith	director	ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129
Aea Growth Equity Fund Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Aea Growth Equity Fund (parallel) Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Ravi Yang Sarin	director	C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067
Brian R Hoesterey	10 percent owner	C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103
Kevin Nazemi	director, officer: Chief Executive Officer	10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004